Dianthus Therapeutics, Inc. (DNTH)
88.51
-3.30
(-3.59%)
USD |
NASDAQ |
Nov 16, 14:12
Dianthus Therapeutics Total Assets (Quarterly) : 1.276B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.276B |
| June 30, 2026 | 1.213B |
| March 31, 2026 | 1.247B |
| December 31, 2025 | 531.40M |
| September 30, 2025 | 577.44M |
| June 30, 2025 | 326.08M |
| March 31, 2025 | 348.58M |
| December 31, 2024 | 374.24M |
| September 30, 2024 | 354.25M |
| June 30, 2024 | 368.96M |
| March 31, 2024 | 382.46M |
| December 31, 2023 | 179.40M |
| September 30, 2023 | 192.46M |
| June 30, 2023 | 78.64M |
| March 31, 2023 | 83.44M |
| December 31, 2022 | 83.11M |
| September 30, 2022 | 164.12M |
| June 30, 2022 | 175.12M |
| Date | Value |
|---|---|
| March 31, 2022 | 194.38M |
| December 31, 2021 | 189.93M |
| September 30, 2021 | 206.24M |
| June 30, 2021 | 220.38M |
| March 31, 2021 | 144.62M |
| December 31, 2020 | 161.62M |
| September 30, 2020 | 174.64M |
| June 30, 2020 | 190.73M |
| March 31, 2020 | 144.44M |
| December 31, 2019 | 161.51M |
| September 30, 2019 | 177.23M |
| June 30, 2019 | 195.44M |
| March 31, 2019 | 147.69M |
| December 31, 2018 | 157.31M |
| September 30, 2018 | 172.79M |
| June 30, 2018 | 180.62M |
| March 31, 2018 | 46.08M |
| December 31, 2017 | 54.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Xencor, Inc. | 770.50M |
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 189.60M |
| Savara, Inc. | 155.93M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 34.82M |
| Shareholders Equity (Quarterly) | 1.241B |
| Debt to Equity Ratio | 0.001 |
| Current Ratio | 30.02 |
| Net Debt Paydown Yield | 0.00% |